| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |